Title : Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

Pub. Date : 2018 Jan 17

PMID : 29343688






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib. Sorafenib WEE1 G2 checkpoint kinase Homo sapiens
2 To overcome this resistance, we used high-throughput screening with a siRNA library directed against 719 human kinases, and Wee1 was selected as a sorafenib response modulator. Sorafenib WEE1 G2 checkpoint kinase Homo sapiens
3 Inhibition of Wee1 by its specific inhibitor MK1775 in combination with sorafenib restored the KRAS mutated cells" response to the multi-target tyrosine kinase inhibitor. Sorafenib WEE1 G2 checkpoint kinase Homo sapiens